
Human Breast Cancer Organoid
Please note: All purchases should be limited to United States.
Purchase order must reference promotion code SUMMER10. The offer is to purchase any of our 3D Ready Organoids for up to 10% off the list price. Valid August 1, 2025 through August 31, 2025.
The offer does not include shipping and handling, installation, or training. The offer does not include any other options or accessories.
This promotion cannot be combined with any other promotions or discounts. No substitutions or swap outs. The discount is not convertible to cash.
Promotion is not valid for standing orders. All prices exclude delivery charges and local taxes, which are the responsibility of the customer.
Purchase orders must be received by August 31, 2025 and delivery completed by December 31, 2025.
Promotion is available in the United States and Canada when buying directly from Molecular Devices. All products are for research use only.
Void where prohibited. The purchase is subject to Molecular Devices standard terms and conditions of sale. https://www.moleculardevices.com/terms-and-conditions.
Additional information on all organoid lines is available – please contact us to learn more.
For complete Terms and Conditions for non-commercial internal research by universities and government agencies, please click here.
Early detection and treatment are crucial in the survival rate of breast cancer patients. This necessitates the use of clinically relevant tumor models to understand the mechanism, analyze tumor biomarkers, and screen anticancer drugs. 3D Ready™ Breast Cancer Organoids provide the platform to study tumor physiology and response to targeted therapies.
Part Number | Product Description | Source | Pathology | ER/PR/Her2 Immuno histochemistry Staining | Number of Organoids per Vial | Price (USD) |
---|---|---|---|---|---|---|
OES-BCO037-CXP1 | 3D Ready™ Breast Cancer Organoid, BCO-037 | PDX | Invasive Ductal Carcinoma | ER-/PR-/Her2- | 250,000 | 3,446 |
We Also Recommend